Xenetic Biosciences, Inc. (XBIO): Shares Outstanding

Annual figures by period end, from SEC filings.

Stock splits: 1-for-10, first reflected in a filing dated 2023-08-10. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2016-12-31, 2017-12-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

2.29M

As of 2025-12-31

2.34M

As of 2026-06-30

+14.7%

3-year compound annual growth

2012-12-31 Shares Outstanding (shares) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period ended	Shares Outstanding	Change YoY	Source filing
2025-12-31	2.29M	+48.6%	2026-03-12, Balance as of period end
2024-12-31	1.54M	+0.1%	2026-03-12, Balance as of period end
2023-12-31	1.54M	+1.6%	2025-03-18, Balance as of period end
2022-12-31	1.52M	n/c	2024-03-21, Balance as of period end
2021-12-31	13.44M	n/c	2023-03-22, Balance as of period end
2020-12-31	8.75M	n/c	2022-03-22, Balance as of period end
2019-12-31	6.07M	n/c	2021-03-16, Balance as of period end
2018-12-31	9.40M	+7.9%	2019-03-29, Balance as of period end
2017-12-31	8.72M	n/c	2019-03-29, Balance as of period end
2016-12-31	4.59M	n/c	2018-03-30, Balance as of period end
2015-12-31	4.59M	-96.7%	2017-03-31, Balance as of period end
2014-12-31	139.30M	+16.2%	2016-03-30, Balance as of period end
2013-12-31	119.89M	0.0%	2015-07-20, Balance as of period end
2012-12-31	119.83M	n/a	2015-07-20, Balance as of period end